The DOI matches its Crossref record; 111 of the 111 references it cites were found in a registry or an index.
Diabetic nephropathy – is this an immune disorder?
Abstract
Chronic diabetes is associated with metabolic and haemodynamic stresses which can facilitate modifications to DNA, proteins and lipids, induce cellular dysfunction and damage, and stimulate inflammatory and fibrotic responses which lead to various types of renal injury. Approximately 30–40% of patients with diabetes develop nephropathy and this renal injury normally progresses in about a third of patients. Due to the growing incidence of diabetes, diabetic nephropathy is now the main cause of end-stage renal disease (ESRD) worldwide. Accumulating evidence from experimental and clinical studies has demonstrated that renal inflammation plays a critical role in determining whether renal injury progresses during diabetes. However, the immune response associated with diabetic nephropathy is considerably different to that seen in autoimmune kidney diseases or in acute kidney injury arising from episodes of ischaemia or infection. This review evaluates the role of the immune system in the development of diabetic nephropathy, including the specific contributions of leucocyte subsets (macrophages, neutrophils, mast cells, T and B lymphocytes), danger-associated molecular patterns (DAMPs), inflammasomes, immunoglobulin and complement. It also examines factors which may influence the development of the immune response, including genetic factors and exposure to other kidney insults. In addition, this review discusses therapies which are currently under development for targeting the immune system in diabetic nephropathy and indicates those which have proceeded into clinical trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pathologic Classification of Diabetic Nephropathy
Tervaert, T. W. C., Mooyaart, A. L., Amann, K., Cohen, A. H., Cook, H. T., Drachenberg, C. B., Ferrario, F., Fogo, A. B., Haas, M., de Heer, E., et al. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010010010 · Cited by 1,690
Transcriptome Analysis of Human Diabetic Kidney Disease
Woroniecka, K. I., Park, A. S. D., Mohtat, D., Thomas, D. B., Pullman, J. M., & Susztak, K. (2011) · Diabetes · doi:10.2337/db10-1181 · Cited by 642
Wendt, T. M., Tanji, N., Guo, J., Kislinger, T. R., Qu, W., Lu, Y., Bucciarelli, L. G., Rong, L. L., Moser, B., Markowitz, G. S., et al. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63909-0 · Cited by 600
The risk of acute renal failure in patients with chronic kidney disease
Hsu, C. Y., Ordoñez, J. D., Chertow, G. M., Fan, D., McCulloch, C. E., & Go, A. S. (2008) · Kidney International · doi:10.1038/ki.2008.107 · Cited by 551
Chow, F., Ozols, E., Nikolic-Paterson, D. J., Atkins, R. C., & Tesch, G. H. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00367.x · Cited by 551
Self-citationTANJI, N., MARKOWITZ, G. S., FU, C., KISLINGER, T., TAGUCHI, A., PISCHETSRIEDER, M., STERN, D., SCHMIDT, A. M., & D'AGATI, V. D. (2000) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1191656 · Cited by 487
Chow, F. Y., Nikolic-Paterson, D. J., Ozols, E., Atkins, R. C., Rollin, B. J., & Tesch, G. H. (2006) · Kidney International · doi:10.1038/sj.ki.5000014 · Cited by 440
Self-citationInflammation in Diabetic Nephropathy
Lim, A. K. H., & Tesch, G. H. (2012) · Mediators of Inflammation · doi:10.1155/2012/146154 · Cited by 437
Self-citationInnate immunity in diabetes and diabetic nephropathy
Wada, J., & Makino, H. (2016) · Nature Reviews Nephrology · doi:10.1038/nrneph.2015.175 · Cited by 427
Modular Activation of Nuclear Factor-κB Transcriptional Programs in Human Diabetic Nephropathy
Schmid, H., Boucherot, A., Yasuda, Y., Henger, A., Brunner, B., Eichinger, F., Nitsche, A., Kiss, E., Bleich, M., Gröne, H.-J., et al. (2006) · Diabetes · doi:10.2337/db06-0477 · Cited by 419
Nlrp3-inflammasome activation in non-myeloid-derived cells aggravates diabetic nephropathy
Shahzad, K., Bock, F., Dong, W., Wang, H., Kopf, S., Kohli, S., Al-Dabet, M. M., Ranjan, S., Wolter, J., Wacker, C., et al. (2015) · Kidney International · doi:10.1038/ki.2014.271 · Cited by 411
The role of the complement system in diabetic nephropathy
Flyvbjerg, A. (2017) · Nature Reviews Nephrology · doi:10.1038/nrneph.2017.31 · Cited by 397
Toll-Like Receptor 4 Promotes Tubular Inflammation in Diabetic Nephropathy
Lin, M., Yiu, W. H., Wu, H. J., Chan, L. Y. Y., Leung, J. C. K., Au, W. S., Chan, K. W., Lai, K. N., & Tang, S. C. W. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010111210 · Cited by 386
NF- B activation and overexpression of regulated genes in human diabetic nephropathy
Mezzano, S., Aros, C., Droguett, A., Burgos, M. E., Ardiles, L., Flores, C., Schneider, H., Ruiz-Ortega, M., & Egido, J. (2004) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfh207 · Cited by 381
Festa, A., D'agostino, R., Howard, G., Mykkänen, L., Tracy, R. P., & Haffner, S. M. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00331.x · Cited by 369
An overview on HMGB1 inhibitors as potential therapeutic agents in HMGB1-related pathologies
Musumeci, D., Roviello, G. N., & Montesarchio, D. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.11.001 · Cited by 334
Macrophage accumulation in human progressive diabetic nephropathy
NGUYEN, D., PING, F., MU, W., HILL, P., ATKINS, R. C., & CHADBAN, S. J. (2006) · Nephrology · doi:10.1111/j.1440-1797.2006.00576.x · Cited by 331
Eller, K., Kirsch, A., Wolf, A. M., Sopper, S., Tagwerker, A., Stanzl, U., Wolf, D., Patsch, W., Rosenkranz, A. R., & Eller, P. (2011) · Diabetes · doi:10.2337/db11-0358 · Cited by 318
Berthier, C. C., Zhang, H., Schin, M., Henger, A., Nelson, R. G., Yee, B., Boucherot, A., Neusser, M. A., Cohen, C. D., Carter-Su, C., et al. (2009) · Diabetes · doi:10.2337/db08-1328 · Cited by 317
Autoimmune Destruction of Pancreatic β Cells
Yoon, J.-W., & Jun, H.-S. (2005) · American Journal of Therapeutics · doi:10.1097/01.mjt.0000178767.67857.63 · Cited by 308
Chow, F. Y., Nikolic-Paterson, D. J., Ozols, E., Atkins, R. C., & Tesch, G. H. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004070612 · Cited by 277
Self-citationde Zeeuw, D., Bekker, P., Henkel, E., Hasslacher, C., Gouni-Berthold, I., Mehling, H., Potarca, A., Tesar, V., Heerspink, H. J. L., & Schall, T. J. (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(15)00261-2 · Cited by 273
Mechanistic insight of diabetic nephropathy and its pharmacotherapeutic targets: An update
Bhattacharjee, N., Barma, S., Konwar, N., Dewanjee, S., & Manna, P. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2016.08.022 · Cited by 271
Possible relationship of monocyte chemoattractant protein-1 with diabetic nephropathy
Banba, N., Nakamura, T., Matsumura, M., Kuroda, H., Hattori, Y., & Kasai, K. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00214.x · Cited by 267
Chow, F. Y., Nikolic-Paterson, D. J., Ma, F. Y., Ozols, E., Rollins, B. J., & Tesch, G. H. (2007) · Diabetologia · doi:10.1007/s00125-006-0497-8 · Cited by 250
Self-citationOf Inflammasomes and Alarmins: IL-1β and IL-1α in Kidney Disease
Anders, H.-J. (2016) · Journal of the American Society of Nephrology · doi:10.1681/asn.2016020177 · Cited by 250
RAGE Control of Diabetic Nephropathy in a Mouse Model
Myint, K.-M., Yamamoto, Y., Doi, T., Kato, I., Harashima, A., Yonekura, H., Watanabe, T., Shinohara, H., Takeuchi, M., Tsuneyama, K., et al. (2006) · Diabetes · doi:10.2337/db06-0221 · Cited by 249
Pathology of Human Diabetic Nephropathy
Najafian, B., Alpers, C. E., & Fogo, A. B. (2011) · Contributions to Nephrology · doi:10.1159/000324942 · Cited by 245
Macrophages in diabetic nephropathy in patients with type 2 diabetes
Klessens, C. Q. F., Zandbergen, M., Wolterbeek, R., Bruijn, J. A., Rabelink, T. J., Bajema, I. M., & IJpelaar, D. H. T. (2017) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfw260 · Cited by 244
Wang, C., Pan, Y., Zhang, Q.-Y., Wang, F.-M., & Kong, L.-D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038285 · Cited by 232
Role of Transcription Factor Acetylation in Diabetic Kidney Disease
Liu, R., Zhong, Y., Li, X., Chen, H., Jim, B., Zhou, M.-M., Chuang, P. Y., & He, J. C. (2014) · Diabetes · doi:10.2337/db13-1810 · Cited by 216
Macrophages in streptozotocin-induced diabetic nephropathy: potential role in renal fibrosis
Chow, F. Y., Nikolic-Paterson, D. J., Atkins, R. C., & Tesch, G. H. (2004) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfh441 · Cited by 206
Self-citationMycophenolate mofetil prevents the development of glomerular injury in experimental diabetes
Utimura, R., Fujihara, C. K., Mattar, A. L., Malheiros, D. M. A. C., de Lourdes Noronha, I., & Zatz, R. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00736.x · Cited by 196
Adhikary, L., Chow, F., Nikolic-Paterson, D. J., Stambe, C., Dowling, J., Atkins, R. C., & Tesch, G. H. (2004) · Diabetologia · doi:10.1007/s00125-004-1437-0 · Cited by 195
Self-citationSuppressors of Cytokine Signaling Abrogate Diabetic Nephropathy
Ortiz-Muñoz, G., Lopez-Parra, V., Lopez-Franco, O., Fernandez-Vizarra, P., Mallavia, B., Flores, C., Sanz, A., Blanco, J., Mezzano, S., Ortiz, A., et al. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009060625 · Cited by 178
Yamaguchi, Y., Iwano, M., Suzuki, D., Nakatani, K., Kimura, K., Harada, K., Kubo, A., Akai, Y., Toyoda, M., Kanauchi, M., et al. (2009) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2009.05.009 · Cited by 168
Macrophages directly mediate diabetic renal injury
You, H., Gao, T., Cooper, T. K., Brian Reeves, W., & Awad, A. S. (2013) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00141.2013 · Cited by 166
Role of Complement and Complement Regulatory Proteins in the Complications of Diabetes
Ghosh, P., Sahoo, R., Vaidya, A., Chorev, M., & Halperin, J. A. (2015) · Endocrine Reviews · doi:10.1210/er.2014-1099 · Cited by 161
Aberrant Recruitment and Activation of T Cells in Diabetic Nephropathy
Moon, J.-Y., Jeong, K.-H., Lee, T.-W., Ihm, C.-G., Lim, S. J., & Lee, S.-H. (2012) · American Journal of Nephrology · doi:10.1159/000334928 · Cited by 161
Lee, F., Cao, Z., Long, D. M., Panagiotopoulos, S., Jerums, G., Cooper, M. E., & Forbes, J. M. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000135055.61833.a8 · Cited by 150
Du, P., Han, H., Han, H., Zhen, J., Shang, J., Wang, X., Li, X., Shi, W., Tang, W., Bao, C., et al. (2013) · Kidney International · doi:10.1038/ki.2013.113 · Cited by 148
Azab, B. N., Daoud, J., Naeem, F. B., Nasr, R., Ross, J. E. V., Ghimire, P., Siddiqui, A., Azzi, N., Rihana, N., Abdallah, M., et al. (2012) · Renal Failure · doi:10.3109/0886022x.2012.668741 · Cited by 148
Haneda, M., Utsunomiya, K., Koya, D., Babazono, T., Moriya, T., Makino, H., Kimura, K., Suzuki, Y., Wada, T., Ogawa, S., et al. (2014) · Clinical and Experimental Nephrology · doi:10.1007/s10157-014-1057-z · Cited by 146
Devaraj, S., Tobias, P. S., Kasinath, B. S., Ramsamooj, R., Afify, A. M., & Jialal, I. (2011) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.228924 · Cited by 146
JAK inhibition in the treatment of diabetic kidney disease
Brosius, F. C., Tuttle, K. R., & Kretzler, M. (2016) · Diabetologia · doi:10.1007/s00125-016-4021-5 · Cited by 145
Niewczas, M. A., Ficociello, L., Johnson, A. C., Walker, W., Rosolowsky, E. T., Roshan, B., Warram, J. H., & Królewski, A. S. (2008) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.03010608 · Cited by 139
Park, C. W., Kim, J., Lee, J. W., Kim, Y. S., Ahn, H. J., Shin, Y. S., Kim, S.-Y., Choi, E. J., Chang, Y. S., & Bang, B. K. (2000) · Diabetologia · doi:10.1007/s001250051567 · Cited by 138
Thurman, J. M., Royer, P. A., Ljubanović, D. G., Dursun, B., Lenderink, A. M., Edelstein, C. L., & Holers, V. M. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005070698 · Cited by 137
Role of Podocyte B7-1 in Diabetic Nephropathy
Fiorina, P., Vergani, A., Bassi, R., Niewczas, M. A., Altintas, M. M., Pezzolesi, M. G., D’Addio, F., Chin, M., Tezza, S., Nasr, M. B., et al. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013050518 · Cited by 132
Mohamed, R., Jayakumar, C., Chen, F., Fulton, D. J., Stepp, D. W., Gansevoort, R. T., & Ramesh, G. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014111136 · Cited by 130
Sayyed, S. G., Ryu, M., Kulkarni, O. P., Schmid, H., Lichtnekert, J., Grüner, S., Green, L., Mattei, P., Hartmann, G. R., & Anders, H. (2011) · Kidney International · doi:10.1038/ki.2011.102 · Cited by 126
JAK inhibition and progressive kidney disease
Brosius, F. C., & He, C. (2014) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000079 · Cited by 124
FcR-Bearing Myeloid Cells Are Responsible for Triggering Murine Lupus Nephritis
Bergtold, A., Gavhane, A., D’Agati, V. D., Madaio, M. P., & Clynes, R. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.10.7287 · Cited by 122
Ho, A. M. ‐., Wong, C. K., & Lam, C. W. K. (2008) · Immunobiology · doi:10.1016/j.imbio.2008.01.003 · Cited by 121
Knockdown of Stat3 activity in vivo prevents diabetic glomerulopathy
Lu, T.-C., Wang, Z., Feng, X., Chuang, P. Y., Fang, W. Y., Shen, Y., Levy, D. E., Xiong, H., Chen, N., & He, C. (2009) · Kidney International · doi:10.1038/ki.2009.98 · Cited by 116
Lim, A. K. H., Nikolic‐Paterson, D. J., Ma, F. Y., Ozols, E., Thomas, M. C., Flavell, R. A., Davis, R. J., & Tesch, G. H. (2008) · Diabetologia · doi:10.1007/s00125-008-1215-5 · Cited by 113
Self-citationTitan, S., Vieira, J. M., Dominguez, W. V., Moreira, S. R. S., Pereira, A. B., Barros, R. T., & Zatz, R. (2012) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2012.06.006 · Cited by 111
Glomerular and tubular induction of the transcription factor c‐Jun in human renal disease
de Borst, M. H., Prakash, J., Melenhorst, W. B. W. H., van den Heuvel, M. C., Kok, R. J., Navis, G. J., & van Goor, H. (2007) · The Journal of Pathology · doi:10.1002/path.2228 · Cited by 110
Integrating albuminuria and GFR in the assessment of diabetic nephropathy
Jerums, G., Panagiotopoulos, S., Premaratne, E., & MacIsaac, R. J. (2009) · Nature Reviews Nephrology · doi:10.1038/nrneph.2009.91 · Cited by 106
Cellular and humoral immune responses in the early stages of diabetic nephropathy in NOD mice
Xiao, X., Ma, B., Dong, B., Zhao, P., Tai, N., Chen, L., Wong, F. S., & Li, W. (2009) · Journal of Autoimmunity · doi:10.1016/j.jaut.2008.12.003 · Cited by 104
Lim, A. K. H., Ma, F. Y., Nikolic‐Paterson, D. J., Thomas, M. C., Hurst, L., & Tesch, G. H. (2009) · Diabetologia · doi:10.1007/s00125-009-1399-3 · Cited by 102
Self-citationSourris, K. C., & Forbes, J. M. (2009) · Current Drug Targets · doi:10.2174/138945009787122905 · Cited by 99
Verzola, D., Cappuccino, L., D’Amato, E., Villaggio, B., Gianiorio, F., Mij, M., Simonato, A., Viazzi, F. C., Salvidio, G., & Garibotto, G. (2014) · Kidney International · doi:10.1038/ki.2014.116 · Cited by 99
Saraheimo, M., Forsblom, C. M., Hansen, T. K., Teppo, A.-M., Fagerudd, J. A., Pettersson-Fernholm, K., Thiel, S., Tarnow, L., Ebeling, P. R., Flyvbjerg, A., et al. (2004) · Diabetologia · doi:10.1007/s00125-004-1594-1 · Cited by 97
Mannose-Binding Lectin and Mortality in Type 2 Diabetes
Hansen, T. K., Gall, M.-A., Tarnow, L., Thiel, S., Stehouwer, C. D. A., Schalkwijk, C. G., Parving, H.-H., & Flyvbjerg, A. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.18.2007 · Cited by 96
ASK1 Inhibitor Halts Progression of Diabetic Nephropathy in Nos3-Deficient Mice
Tesch, G. H., Ma, F. Y., Han, Y., Liles, J. T., Breckenridge, D. G., & Nikolic‐Paterson, D. J. (2015) · Diabetes · doi:10.2337/db15-0384 · Cited by 95
Self-citationKidney Outcomes in Long-Term Studies of Ruboxistaurin for Diabetic Eye Disease
Tuttle, K. R., McGill, J. B., Haney, D. J., Lin, T. E., & Anderson, P. W. (2007) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.00840207 · Cited by 94
Macrophage Cyclooxygenase-2 Protects Against Development of Diabetic Nephropathy
Wang, X., Yao, B., Wang, Y., Fan, X., Wang, S., Niu, A., Yang, H., Fogo, A. B., Zhang, M., & Harris, R. C. (2016) · Diabetes · doi:10.2337/db16-0773 · Cited by 90
Serum Inflammatory and Immune Mediators Are Elevated in Early Stage Diabetic Nephropathy.
Perlman, A. S., Chevalier, J. M., Wilkinson, P. F., Liu, H., Parker, T. S., Levine, D. M., Sloan, B., Gong, A., Sherman, R. L., & Farrell, F. X. (2015) · PubMed · Cited by 88
Kolati, S. R., Kasala, E. R., Bodduluru, L. N., Mahareddy, J. R., Uppulapu, S. K., Gogoi, R., Barua, C. C., & Lahkar, M. (2015) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2015.01.019 · Cited by 87
Lim, A. K. H., Ma, F. Y., Nikolic‐Paterson, D. J., Kitching, A. R., Thomas, M. C., & Tesch, G. H. (2010) · Diabetologia · doi:10.1007/s00125-010-1757-1 · Cited by 82
Self-citationGao, P., Meng, X., Su, H., He, F.-F., Chen, S., Tang, H. R., Tian, X., Fan, D., Wang, Y., Liu, J.-S., et al. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2014.07.001 · Cited by 80
Zou, L., Feng, Y., Li, Y., Zhang, M., Chen, C., Cai, J., Gong, Y., Wang, L. L., Thurman, J. M., Wu, X., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1301903 · Cited by 79
Shoukry, A., Bdeer, S. E., & El-Sokkary, R. H. (2015) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-015-2479-y · Cited by 73
Kelly, K. J., & Dominguez, J. H. (2010) · American Journal of Nephrology · doi:10.1159/000320749 · Cited by 69
Targeting T helper 17 by mycophenolate mofetil attenuates diabetic nephropathy progression
Kim, S.-M., Lee, S. H., Lee, A., Kim, D.-J., Kim, Y., Kim, S., Jeong, K.-H., Lee, T., Ihm, C., Lim, S., et al. (2015) · Translational research · doi:10.1016/j.trsl.2015.04.013 · Cited by 65
Zheng, J., Yao, G., Cheng, Z., Wang, R., & Liu, Z. (2011) · Diabetologia · doi:10.1007/s00125-011-2391-2 · Cited by 65
Postischemic inflammatory syndrome: a critical mechanism of progression in diabetic nephropathy
Kelly, K. J., Burford, J. L., & Dominguez, J. H. (2009) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00205.2009 · Cited by 65
Moriya, R., Manivel, J. C., & Mauer, M. S. (2004) · Diabetologia · doi:10.1007/s00125-003-1253-y · Cited by 64
Li, L., Yin, Q., Tang, X., Bai, L., Zhang, J., Gou, S., Zhu, H., Cheng, J., Fu, P., & Liu, F. (2014) · PLoS ONE · doi:10.1371/journal.pone.0113639 · Cited by 64
Ijaz, A., Tejada, T., Catanuto, P., Xia, X., Elliot, S. J., Lenz, O., Jauregui, A. N., Saenz, M. O., Molano, R. D., Pileggi, A., et al. (2008) · Kidney International · doi:10.1038/ki.2008.559 · Cited by 64
Proteinuria and Activated T-Lymphocytes in Diabetic Nephropathy
Bending, J. J., Lobo-Yeo, A., Vergani, D., & Viberti, G. C. (1988) · Diabetes · doi:10.2337/diab.37.5.507 · Cited by 63
Lipid and inflammatory biomarkers and kidney function decline in type 2 diabetes
Lin, J., Hu, F. B., Mantzoros, C. S., & Curhan, G. C. (2009) · Diabetologia · doi:10.1007/s00125-009-1597-z · Cited by 63
Protective Effects of Toll-like Receptor 4 Inhibitor Eritoran on Renal Ischemia-Reperfusion Injury
Liu, M., Gu, M., Xu, D., Lv, Q., Zhang, W., & Wu, Y. (2010) · Transplantation Proceedings · doi:10.1016/j.transproceed.2010.03.133 · Cited by 63
Increased Expression of Toll-Like Receptor 2 in Rat Diabetic Nephropathy
Li, F., Yang, N., Zhang, L., Tan, H., Huang, B., Liang, Y., Chen, M., & Yu, X. (2010) · American Journal of Nephrology · doi:10.1159/000317023 · Cited by 63
Toll-Like Receptor 4 Inhibitor TAK-242 Attenuates Acute Kidney Injury in Endotoxemic Sheep
Fenhammar, J., Rundgren, M., Forestier, J., Kalman, S., Eriksson, S., & Frithiof, R. (2011) · Anesthesiology · doi:10.1097/aln.0b013e31820b8b44 · Cited by 62
Chymase: Its Pathophysiological Roles and Inhibitors
Fukami, R., Okunishi, R., & Miyazaki, M. (1998) · Current Pharmaceutical Design · doi:10.2174/138161280406221011112056 · Cited by 61
Renal C3 Complement Component: Feed Forward to Diabetic Kidney Disease
Kelly, K. J., Liu, Y., Zhang, J., & Dominguez, J. H. (2015) · American Journal of Nephrology · doi:10.1159/000371426 · Cited by 58
Shang, J., Zhang, Y., Jiang, Y., Li, Z., Duan, Y., Wang, L., Xiao, J., & Zhao, Z. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.01.155 · Cited by 57
Nazir, N., Siddiqui, K., Al-Qasim, S., & Alnaqeb, D. (2014) · BMC Medical Genetics · doi:10.1186/s12881-014-0103-8 · Cited by 56
Wu, Y., Wu, G., Qi, X., Lin, H., Qian, H., Shen, J., & Lin, S. (2006) · Journal of Pharmacological Sciences · doi:10.1254/jphs.fp0050896 · Cited by 55
Albumin-induced podocyte injury and protection are associated with regulation of COX-2
Agrawal, S., Guess, A. J., Chanley, M. A., & Smoyer, W. E. (2014) · Kidney International · doi:10.1038/ki.2014.196 · Cited by 55
Long-Term Treatment of Sirolimus but Not Cyclosporine Ameliorates Diabetic Nephropathy in the Rat
Wittmann, S., Daniel, C., Stief, A., Vogelbacher, R., Amann, K., & Hugo, C. (2009) · Transplantation · doi:10.1097/tp.0b013e3181a192bd · Cited by 50
Suzuki, D., Toyoda, M., Yamamoto, N., Miyauchi, M., Katoh, M., Kimura, M., Maruyama, M., Honma, M., Umezono, T., & Yagame, M. (2006) · Internal Medicine · doi:10.2169/internalmedicine.45.1557 · Cited by 50
Complement Activation Accelerates Glomerular Injury in Diabetic Rats
Fujita, T., Ohi, H., Komatsu, K., Endo, M., Ohsawa, I., & Kanmatsuse, K. (1999) · The Nephron journals/Nephron journals · doi:10.1159/000045278 · Cited by 42
Lopes-Virella, M. F., Carter, R. E., Baker, N. L., Lachin, J. M., & Virella, G. (2011) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfr454 · Cited by 42
Jones, S. E., Gilbert, R. E., & Kelly, D. J. (2004) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2004.02.002 · Cited by 40
Ma, J., Wu, H., Zhao, C. Y., Panchapakesan, U., Pollock, C. A., & Chadban, S. J. (2014) · Europe PMC (PubMed Central) · Cited by 39
Fcγ Receptor Deficiency Attenuates Diabetic Nephropathy
López-Parra, V., Mallavia, B., López‐Franco, Ó., Ortiz-Muñoz, G., Oguiza, A., Recio, C., Blanco, J., Nimmerjahn, F., Egido, J., & Gómez‐Guerrero, C. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011080822 · Cited by 39
B7–1 Is Not Induced in Podocytes of Human and Experimental Diabetic Nephropathy
Gagliardini, E., Novelli, R., Corna, D., Zoja, C., Ruggiero, B., Benigni, A., & Remuzzi, G. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2015030266 · Cited by 38
Lim, A. K. H., Ma, F. Y., Nikolic‐Paterson, D. J., Ozols, E., Young, M. J., Bennett, B. L., Friedman, G. C., & Tesch, G. H. (2011) · American Journal of Nephrology · doi:10.1159/000331058 · Cited by 38
Self-citationLangham, R. G., Kelly, D. J., Gow, R. M., Zhang, Y., Cox, A. J., Qi, W., Thai, K., Pollock, C. A., Christensen, P. K., Parving, H., et al. (2008) · Diabetologia · doi:10.1007/s00125-008-0927-x · Cited by 37
Suppressor of Cytokine Signaling-1 Ameliorates Expression of MCP-1 in Diabetic Nephropathy
Shi, Y., Du, C., Zhang, Y., Ren, Y., Hao, J., Song, Z., Yao, F., & Duan, H. (2010) · American Journal of Nephrology · doi:10.1159/000286559 · Cited by 33
Zhang, L., Liu, J. J., Xue, C., Li, M., Xing, S., Zhang, X., He, W., Jiang, F., Xia, L., & Zhou, P. (2016) · Scientific Reports · doi:10.1038/srep26954 · Cited by 33
Herrera, M., Söderberg, M. P., Sabirsh, A., Valastro, B., Mölne, J., Santamaría, B., Valverde, Á. M., Guionaud, S., Heasman, S. C., Bigley, A. L., et al. (2016) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00179.2016 · Cited by 32
Genetics and Epigenetics of Diabetic Nephropathy
Liu, R., Lee, K., & He, C. (2015) · Kidney Diseases · doi:10.1159/000381796 · Cited by 31
Tesch, G. H., Sourris, K. C., Summers, S. A., McCarthy, D. A., Ward, M. S., Borg, D. J., Gallo, L. A., Fotheringham, A. K., Pettit, A. R., Yap, F. Y. T., et al. (2014) · Diabetologia · doi:10.1007/s00125-014-3291-z · Cited by 31
Self-citationLopes-Virella, M. F., Hunt, K. J., Baker, N. L., & Virella, G. (2016) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2016.01.012 · Cited by 24
Bhat, S., Jagadeeshaprasad, M. G., Patil, Y. R., Shaikh, M. L., Regin, B., Mohan, V., Giri, A. P., Balasubramanyam, M., Boppana, R., & Kulkarni, M. J. (2016) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m116.058008 · Cited by 21
Rempel, L. C. T., Becker-Finco, A., Maciel, R. A. P., Bosquetti, B., Alvarenga, L. M., de Souza, W. M., Pecoits‐Filho, R., & Stinghen, A. E. M. (2015) · Toxins · doi:10.3390/toxins7051722 · Cited by 16
Zhang, X., Xing, S., Li, M., Zhang, L., Xie, L., He, W., Liu, J., Chang, S., Jiang, F., & Zhou, P. (2016) · Metabolism · doi:10.1016/j.metabol.2016.05.005 · Cited by 16
Cited by
Inflammation in obesity, diabetes, and related disorders
Rohm, T. V., Meier, D. T., Olefsky, J. M., & Donath, M. Y. (2022) · Immunity · doi:10.1016/j.immuni.2021.12.013 · Cited by 2,066
Macrophages: versatile players in renal inflammation and fibrosis
Tang, P. M.-K., Nikolic-Paterson, D. J., & Lan, H.-Y. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0110-2 · Cited by 1,033
Targeting innate immune mediators in type 1 and type 2 diabetes
Donath, M. Y., Dinarello, C. A., & Mandrup-Poulsen, T. (2019) · Nature Reviews Immunology · doi:10.1038/s41577-019-0213-9 · Cited by 416
Bonnet, F., & Scheen, A. J. (2018) · Diabetes & Metabolism · doi:10.1016/j.diabet.2018.09.005 · Cited by 308
Immune responses in diabetic nephropathy: Pathogenic mechanisms and therapeutic target
Chen, J., Liu, Q., He, J., & Li, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.958790 · Cited by 164
Metadata
- Authors
- Tesch, G. H.
- Venue
- Clinical Science
- Publisher
- Portland Press Ltd.
- Published
- 2017-07-31
- Volume
- 131
- Issue
- 16
- Pages
- 2183-2199
- ISSN
- 0143-5221 (ISSN-L)
- 1470-8736
- OpenAlex
- W2739698179
- Cited by
- 264
- References
- 111
- FWCI
- 15.44
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.